Local and metastatic relapse of prostate cancer often occur following attempted curative resection of the primary tumor and up to 66% of local recurrences are associated with positive margins. Therefore, technologies that can improve the visualization of tumor margins and adjuvant therapies to ablate remaining tumor tissues are needed during surgical resection of prostate adenocarcinoma.